tRNA therapeutics burst onto startup scene - Nature
文章推薦指數: 80 %
Companies advance tRNA therapeutics to overcome mutant stoppages in protein synthesis shared by thousands of genetic diseases and cancers. Skiptomaincontent Thankyouforvisitingnature.com.YouareusingabrowserversionwithlimitedsupportforCSS.Toobtain thebestexperience,werecommendyouuseamoreuptodatebrowser(orturnoffcompatibilitymodein InternetExplorer).Inthemeantime,toensurecontinuedsupport,wearedisplayingthesitewithoutstyles andJavaScript. Advertisement nature naturebiotechnology news article CompaniesadvancetRNAtherapeuticstoovercomemutantstoppagesinproteinsynthesissharedbythousandsofgeneticdiseasesandcancers. ButAlltrnaishardlyaloneinitspursuitoftRNA-basedtherapeutics.ReCodeTherapeutics,ShapeTherapeuticsandTevardBiosciencesallcamebeforeit;andthefieldcontinuestoexpandwiththearrivalofhCBioscience,astartupthatemergedfromstealthmodeinlateFebruarywith$24millionandaplantofightcancerandrarediseaseswithtRNA. Thisisapreviewofsubscriptioncontent Accessoptions Accessthroughyourinstitution Changeinstitution Buyorsubscribe SubscribetoJournalGetfulljournalaccessfor1year92,52€only7,71€perissueSubscribeAllpricesareNETprices.VATwillbeaddedlaterinthecheckout.Taxcalculationwillbefinalisedduringcheckout.BuyarticleGettimelimitedorfullarticleaccessonReadCube.$32.00BuyAllpricesareNETprices. Additionalaccessoptions: Login Learnaboutinstitutionalsubscriptions AuthorinformationAuthorsandAffiliationsSomerville,MA,USAElieDolginAuthorsElieDolginViewauthorpublicationsYoucanalsosearchforthisauthorin PubMed GoogleScholarRightsandpermissionsReprintsandPermissionsAboutthisarticleCitethisarticleDolgin,E.tRNAtherapeuticsburstontostartupscene. NatBiotechnol40,283–286(2022).https://doi.org/10.1038/s41587-022-01252-yDownloadcitationPublished:24February2022IssueDate:March2022DOI:https://doi.org/10.1038/s41587-022-01252-ySharethisarticleAnyoneyousharethefollowinglinkwithwillbeabletoreadthiscontent:GetshareablelinkSorry,ashareablelinkisnotcurrentlyavailableforthisarticle.Copytoclipboard ProvidedbytheSpringerNatureSharedItcontent-sharinginitiative Accessthroughyourinstitution Changeinstitution Buyorsubscribe Advertisement Explorecontent Researcharticles Reviews&Analysis News&Comment Podcasts Videos Currentissue Collections FollowusonFacebook FollowusonTwitter Subscribe Signupforalerts RSSfeed Aboutthejournal Aims&Scope JournalInformation JournalMetrics AbouttheEditors Ourpublishingmodels EditorialValuesStatement EditorialPolicies ContentTypes WebFeeds Posters Contact Publishwithus SubmissionGuidelines ForReviewers Submitmanuscript Search Searcharticlesbysubject,keywordorauthor Showresultsfrom Alljournals Thisjournal Search Advancedsearch Quicklinks Explorearticlesbysubject Findajob Guidetoauthors Editorialpolicies Closebanner Close SignupfortheNatureBriefingnewsletter—whatmattersinscience,freetoyourinboxdaily. Emailaddress Signup IagreemyinformationwillbeprocessedinaccordancewiththeNatureandSpringerNatureLimitedPrivacyPolicy. Closebanner Close Getthemostimportantsciencestoriesoftheday,freeinyourinbox. SignupforNatureBriefing
延伸文章資訊
- 1生物化學與分子生物學/胺基酸與tRNA的連接 - Wikibooks
參與肽鏈合成的胺基酸需要與相應tRNA 結合,形成各種氨醯-tRNA。該過程是由氨醯-tRNA 合成酶(aminoacyl-tRNA synthetase)所催化的耗能反應。胺基酸與特異的tRN...
- 2轉運RNA_百度百科
轉運RNA(Transfer RNA),又稱傳送核糖核酸、轉移核糖核酸,通常簡稱為tRNA,是一種由76-90個核苷酸所組成的RNA,其3'端可以在氨酰-tRNA合成酶催化之下,接附特定種類 ...
- 3轉運核糖核酸- 維基百科,自由的百科全書
轉運核糖核酸(Transfer RNA),又稱傳送核糖核酸、轉移核糖核酸,通常簡稱為tRNA,是一種由76-90個核苷酸所組成的RNA,其3'端可以在胺醯-tRNA合成酶催化之下,接附 ...
- 4转运核糖核酸- 维基百科,自由的百科全书
转运核糖核酸(Transfer RNA),又称傳送核糖核酸、转移核糖核酸,通常简称為tRNA,是一種由76-90個核苷酸所組成的RNA,其3'端可以在氨酰-tRNA合成酶催化之下,接附 ...
- 5轉運RNA(transfer RNA, tRNA) - 小小整理網站Smallcollation
轉運RNA(transfer RNA, tRNA) ; Dihydrouridine(D). 將尿嘧啶(U)上的-C=C-雙鍵還原成單鍵而成 ; Pseudouridine(Ψ). 正常尿嘧啶(...